Who owns ArriVent BioPharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AVBP from SEC Form 13F filings across 157 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 157 institutions disclosed 46.1M shares of ArriVent BioPharma, Inc. worth $1.60B — about 96.9% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
157
13F holders
$1.60B
value, 2026 filers
96.9%
of shares outstanding (46.1M sh)
35
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of AVBP's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 4.5M | $156.9M | 2.9% | 9.5% | +2.6% |
| 2 | INFINITUM ASSET MANAGEMENT, LLC | 4.4M | $154.2M | 15.7% | 9.3% | +7.0% |
| 3 | HHLR ADVISORS, LTD. | 3.9M | $136.5M | 16.4% | 8.3% | 0.0% |
| 4 | BlackRock, Inc. | 3.3M | $112.9M | 0.0% | 6.8% | +28.5% |
| 5 | ORBIMED ADVISORS LLC | 3.0M | $105.2M | 1.9% | 6.4% | 0.0% |
| 6 | FMR LLC | 2.8M | $96.5M | 0.0% | 5.8% | -7.9% |
| 7 | Octagon Capital Advisors LP | 2.0M | $68.5M | 6.2% | 4.1% | 0.0% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $61.7M | 0.0% | 3.7% | +16.1% |
| 9 | Sofinnova Investments, Inc. | 1.7M | $58.9M | 3.0% | 3.6% | 0.0% |
| 10 | STATE STREET CORP | 1.7M | $58.8M | 0.0% | 3.6% | +19.1% |
| 11 | Vivo Capital, LLC | 1.7M | $58.4M | 5.3% | 3.5% | +89.9% |
| 12 | NOVO HOLDINGS A/S | 1.5M | $52.1M | 3.0% | 3.2% | -22.8% |
| 13 | General Catalyst Group Management, LLC | 1.5M | $51.9M | 27.5% | 3.1% | 0.0% |
| 14 | Logos Global Management LP | 1.0M | $34.7M | 1.5% | 2.1% | +185.7% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 972,626 | $33.8M | 0.0% | 2% | +21.0% |
| 16 | D. E. Shaw & Co., Inc. | 872,011 | $30.3M | 0.0% | 1.8% | +136.4% |
| 17 | GOLDMAN SACHS GROUP INC | 853,723 | $29.7M | 0.0% | 1.8% | 0.0% |
| 18 | HSG Holding Ltd | 663,308 | $23.0M | 1.9% | 1.4% | 0.0% |
| 19 | Point72 Asset Management, L.P. | 566,796 | $19.7M | 0.0% | 1.2% | -24.2% |
| 20 | MILLENNIUM MANAGEMENT LLC | 438,664 | $15.2M | 0.0% | 0.9% | +3.0% |
| 21 | UBS Group AG | 438,594 | $15.2M | 0.0% | 0.9% | -9.8% |
| 22 | Balyasny Asset Management L.P. | 395,447 | $13.7M | 0.0% | 0.8% | -7.2% |
| 23 | AMERIPRISE FINANCIAL INC | 381,589 | $13.3M | 0.0% | 0.8% | +112.0% |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | 335,320 | $11.6M | 0.0% | 0.7% | +32.1% |
| 25 | NORTHERN TRUST CORP | 332,753 | $11.6M | 0.0% | 0.7% | +23.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.